Long-term outcomes in non-diabetic patients with metabolic syndrome undergoing revascularization for multi-vessel coronary artery disease

Atherosclerosis

Volumn 198, Issue 2, 2008, Pages 389-395

  Yatskar, Leonid ^a   Holper, Elizabeth ^b   Bansilal, Sameer ^c   Schwartzbard, Arthur ^a   Lombardero, Manuel ^d   Ramanathan, Krishnan ^e   Feit, Frederick ^a   Fisher, Edward ^a   Faxon, David ^f   Hochman, Judith S ^a   Farkouh, Michael E ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e VANCOUVER GENERAL HOSPITAL   (Canada)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Coronary revascularization; Metabolic syndrome; Multi vessel coronary artery disease

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE;

AGED; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 43949132102     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.09.046     Document Type: Article

References (19)

1. Reaven G.M. Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
2. Laws A., and Reaven G.M. Insulin resistance and risk factors for coronary heart disease. Bailliers Clin Endocrinol Metab 7 (1993) 1063-1078
3. Miranda P.J., DeFronzo R.A., Califf R.M., et al. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J 149 (2005) 33-45
4. Lorenzo C., Okoloise M., Williams K., Stern M.P., and Haffner S.M. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26 11 (2003) 3153-3159
5. Laaksonen D.E., Lakka H.M., Niskanen L.K., et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156 11 (2002) 1070-1077
6. Tuomilehto J., Lindstrom J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 (2001) 1343-1350
7. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or Metformin. N Engl J Med 346 (2002) 393-403
8. Alexander C.M., Landsman P.B., Teutsch S.M., and Haffner S.M. Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52 5 (2003) 1210-1214
9. Yip J., Facchini F.S., and Reaven G.M. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 83 (1998) 2773-2776
10. Isomaa B., Almgren P., Tami T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
11. Egan B.M., Greene E.L., and Goodfriend T.L. Insulin resistance and cardiovascular disease. Am J Hypertens 14 (2001) 116S-125S
12. Trevisan M., Liu J., Bahsas F.B., and Menotti A. Syndrome X and mortality: a population based study: Risk Factor and Life Expectancy Research Group. Am J Epidemiol 148 (1998) 958-966
13. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
14. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
15. McNeill A.M., Rosamond W.D., Girman C.J., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28 2 (2005) 385-390
16. Protocol for the Bypass Angioplasty Revascularization Investigation. Circulation 84 Suppl. V (1991) V1-V27
17. Bourassa M.G., Roubin G.S., Detre K.M., et al. Bypass Angioplasty Revascularization Investigation: patient screening, selection and recruitment. Am J Cardiol 75 (1995) 3C-8C
18. Zhu S., Wang Z., Heshka S., et al. Waist circumference and obesity associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr 76 4 (2002) 743-749
19. Levantesi G., Macchia A., Marfisi R., et al. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol 46 2 (2005) 277-283